Skip to main content
| News

Basel Area cantons publish joint economic report

13.07.2020

The cantons of Basel-Landschaft, Basel-Stadt and Jura have just published their first joint Economic Report. The fundamental environment is described as “good” in the report.

View into the Basel Area

A good environment is absolutely essential for success in business. This is most certainly offered by the three cantons in the Basel Area at the moment. According to the press release on the Economic Report published by the cantons of Basel-Stadt, Basel-Landschaft and Jura, “they will continue to develop their potential in future as well”. The report offers an optimistic look ahead, while taking into account the changes brought about by the consequences of the coronavirus crisis and lockdown, stoppages and the restructuring of international working and supply channels. Time and again, the regional economy has shown in the past that it is competent at responding to change and evolving in a positive direction.

The three cantons have been collaborating closely on matters of economic policy for many years. It therefore makes sense for the governments to compile a joint Economic Report, with this being the first time they have done so. Basel-Stadt and Basel-Landschaft last published a report in 2016.

Based on this analysis, opportunities and challenges for the future have been compiled and specified. In particular, the plan is to work together on state innovation funding and location promotion, as more can be achieved through collaboration than if each canton focuses on its own activities as they have done until now.

At the heart of the adopted approach for the future is the investment and innovation promotion agency Basel Area Business & Innovation, which is already funded by the three cantons. With BaselArea’s range of services and the Switzerland Innovation Park Basel Area, the region aims to create the perfect environment for companies, research and innovation, offering all that research and development, service providers and investors need for international communication and marketing.

The second Supplementary Report analyses the impact of COVID-19 on Basel-Stadt as a business location.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.